Data / Form D filings / Schrodinger, Inc.
Schrodinger, Inc.: Form D filings
Schrodinger, Inc., a biotechnology company in New York, NY, filed 5 Form D notices with the SEC between 2010 and 2019. The latest, on May 8, 2019, reports $107.8 million sold of a $115 million offering to 13 investors.
Find out what Schrodinger, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 WEST 45TH STREET, 17TH FLOOR, New York, NY, 10036
- Phone
- (503) 299-1150
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1490978
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2019 | Amendment | $115,000,000 | $107,824,987 | $7,175,013 | 13 | Nov 9, 2018 | sec.gov |
| Nov 14, 2018 | New notice | $99,999,993 | $79,999,994 | $19,999,999 | 6 | Nov 9, 2018 | sec.gov |
| Jun 19, 2015 | New notice | $22,000,000 | $22,000,000 | $0 | 2 | Jun 15, 2015 | sec.gov |
| Dec 17, 2012 | New notice | $20,000,000 | $20,000,000 | $0 | 1 | Dec 11, 2012 | sec.gov |
| May 5, 2010 | New notice | $10,000,000 | $10,000,000 | $0 | 0 | Apr 27, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joel Lebowitz | Executive Officer | |
| Rosana Kapeller-Liebermann | Director | |
| Cony D'Cruz | Executive Officer | |
| Yvonne Tran | Executive Officer | |
| Michael Lynton | Director | |
| Timothy Wright | Director | |
| Richard Friesner | Director | |
| Ramy Farid | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of May 6, 2019 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Schrodinger, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.